BurnsAdler Pharmaceuticals licenses and acquires rights to pharmaceuticals primarily outside the continental United States.  We promote and sell our pharmaceuticals via our sales representatives and local partners around the world.  For name patient programs and Orphan/niche products we market directly to clinics, physician offices and hospitals in more than 15 countries. [MORE]

March 5, 2007              BurnsAdler Partners with X-GEN to Return Colistimethate for Injection to the Mexican Market

January 9, 2007            BurnsAdler and Serral Enter into a Promotional Agreement

August 1, 2006                     BurnsAdler Licenses Gentamicin Surgical Implant from Innocoll

February 1, 2006                     New Promotion Agreement with Sigma-Tau